Table 2. VCOPF Use Satisfaction and Comparison to Other Products by RAD Status.

 VCOPF: Virgin coconut oil in paste form; RAD: rheumatic autoimmune diseases.

	RAD
	No	Yes	Total
	n = 22	n = 31	n = 53	p
Q9 Comparison to non-coconut oil or non-estrogen vaginally applied products n (%)				0.195
VCOPF  is superior	17 (81.0%)	29 (96.7%)	46 (90.2%)
VCOPF is comparable	3 (14.3%)	1 (3.3%)	4 (7.8%)
VCOPF is inferior	1 (4.8%)	0 (0)	1 (2.0%)
N/A	1	1	2
Q10 Comparison to intravaginal estrogen applied therapy n (%)				0.579
VCOPF is superior	15 (79.0%)	15 (88.2%)	30 (83.3%)
VCOPF is comparable	3 (15.8%)	2 (11.8%)	5 (13.9%)
VCOPF is inferior	1 (5.3%)	0 (0)	1 (2.8%)
N/A	3	14	17
Q14 Did VCOPF during intercourse improve or have a positive effect on any of the following? (Yes Only) n (%)
Vaginal dryness	17 (77.3%)	26 (86.7%)	43 (82.7%)	0.468
Duration of vaginal moisture	16 (76.2%)	29 (93.6%)	45 (86.5%)	0.104±
Libido	14 (63.6%)	19 (61.3%)	33 (62.3%)	1
Ability to obtain an orgasm	15 (68.2%)	19 (61.3%)	34 (64.2%)	0.467
Intensity of orgasm during intercourse	12 (54.6%)	16 (51.6%)	28 (52.8%)	0.247
Texture and appearance of skin	5 (22.7%)	10 (33.3%)	15 (28.9%)	0.201
Dryness of mouth	2 (9.1%)	7 (22.6%)	9 (17.0%)	0.284
Dryness of eyes	2 (9.1%)	6 (19.4%)	8 (15.1%)	0.563
Relationship with spouse/partner	15 (68.2%)	26 (83.9%)	41 (77.4%)	0.097*
Prevented breakup with spouse/partner	2 (9.1%)	4 (13.3%)	6 (11.5%)	0.359
Depression	7 (33.3%)	11 (35.5%)	18 (34.6%)	0.546
Anxiety	9 (40.9%)	7 (22.6%)	16 (30.2%)	0.319
Irritability	5 (22.7%)	9 (29.0%)	14 (26.4%)	0.775
Work-related productivity	2 (9.1%)	8 (25.8%)	10 (18.9%)	0.135
Quality of work-related duties	3 (13.6%)	5 (16.7%)	8 (15.4%)	0.696
General quality of life	16 (72.7%)	23 (74.2%)	39 (73.6%)	1
RAD activity	0 (0)	14 (45.2%)	n/a	< .0001>